https://prabadinews.com/
  • October 8, 2026
  • Last Update July 17, 2026 9:28 pm
  • United States of America

33 states pick up CMS program to pay for sickle cell gene therapies

33 states pick up CMS program to pay for sickle cell gene therapies

States representing about 84% of Medicaid beneficiaries are participating in an initiative that enables the U.S. government to negotiate pay-for-performance deals with the manufacturers of products like Casgevy and Lyfgenia.

administrator

Related Articles